ACCYY vs UHS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ACCYY · ACCOR SA SPON ADR EA REPR 0.2 ORD SHS$11.14 ▲ 0.27%
UHS · Universal Health Services$195.50 ▼ 1.56%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ACCYY +6.0%
- UHS -11.8%
Head to head
| Metric | ACCYY | UHS |
|---|---|---|
| Price | $11.14 | $195.50 |
| Change today | ▲ 0.27% | ▼ 1.56% |
| Market cap | $11.51B | $11.52B |
| Return, 3 months | +4.3% | +13.3% |
| Return, year to date | +2.4% | -10.0% |
| Return, 1 year | +8.3% | -14.3% |
| P/E (TTM) | 41.3 | 8.2 |
| P/B | 3.8 | 1.5 |
| P/E percentile vs own 5y | – | 9th |
| Dividend yield | 2.81% | 0.41% |
| Revenue growth (YoY, latest qtr) | – | +5.3% |
| Net profit growth (YoY) | – | -17.3% |
| Gross margin | – | 90.7% |
| Operating margin | – | 10.8% |
| Net margin | – | 8.0% |
| Return on equity | – | 19.8% |
| Analyst target vs. price | – | +2.1% |
| Analyst buy share | – | 40% |
| RSI (14) | 61 | 62 |
| 30-day volatility | 40.0% | 41.2% |
| Max drawdown, 1 year | -24.7% | -42.0% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- UHS is the largest of the group by market value.
- ACCYY has returned the most over the past year.
- UHS carries the lowest trailing P/E.
- ACCYY pays the highest dividend yield.
- ACCYY has been the calmest stock over the last 30 days.